Prof. Stephen Graham | From Hospitals to Households: How Decentralised Care Is Transforming Tuberculosis Treatment for Children

Prof. Stephen Graham | From Hospitals to Households: How Decentralised Care Is Transforming Tuberculosis Treatment for Children

Tuberculosis remains one of the world’s oldest and most stubborn infectious diseases, yet the way health systems respond to it is often dogged by modern challenges. Clinics are overcrowded, families must travel long distances, and children with vague or non-specific symptoms are frequently overlooked. For decades, tuberculosis care has been organised around hospitals and specialised facilities, even though the disease itself spreads and takes root in homes and communities. A growing body of research now argues that this mismatch is costing lives, particularly among children. Decentralised models of care, which bring services closer to families and empower community-based health workers, offer a compelling alternative. Recent evidence from multiple settings shows that when tuberculosis care is shifted out of distant clinics and into neighbourhoods and households, access expands with potential to close the current gaps in TB detection, treatment outcomes and prevention that benefit communities and families, including their children.

Dr. Jürgen Gailer | Linking the Blood Chemistry of Metals with Adverse Human Health: New Tools Reveal an Invisible World

Dr. Jürgen Gailer | Linking the Blood Chemistry of Metals with Adverse Human Health: New Tools Reveal an Invisible World

Researchers Maryam Doroudian and Jürgen Gailer from the University of Calgary explore what happens when red blood cells rupture and release a zinc-containing enzyme called carbonic anhydrase 1 into the bloodstream, revealing that it remains unexpectedly free and may influence vascular health. Their work also connects to broader research showing how liquid chromatography is transforming our ability to study toxic cadmium and mercury as they move through the body. Together, these studies uncover hidden biochemical processes that shape how environmental pollutants and blood-cell damage affect human health.

Easing the Hardest Moment: How Brain Stimulation Is Transforming Care for People with Opioid Use Disorder

Easing the Hardest Moment: How Brain Stimulation Is Transforming Care for People with Opioid Use Disorder

In the world of opioid addiction treatment, the hardest moment often arrives precisely when hope begins to emerge. It is the moment someone chooses to stop using opioids. That decision, courageous and life-changing, almost immediately collides with one of the most punishing physiologic syndromes known in medicine: opioid withdrawal. Withdrawal brings waves of nausea, sweats, shaking, cramps, insomnia, anxiety, and extremely intense cravings. For countless individuals, this moment is a seemingly inescapable stumbling block that can be the undoing of their recovery. They want to stop, they mean to stop, but withdrawal can become an insurmountable barrier.

Dr. Rasha Bayoumi | Decolonizing Global Collaboration: Building Equitable Science Diplomacy

Dr. Rasha Bayoumi | Decolonizing Global Collaboration: Building Equitable Science Diplomacy

Science diplomacy, meaning the use of scientific collaboration to strengthen international relations and address shared global challenges, has long been hailed as a force for good. Yet, as Dr. Rasha Bayoumi of the University of Birmingham Dubai and her colleagues argue in their Editorial for a special issue in the journal Frontiers in Public Health, this optimism often masks uncomfortable realities. The practice of science diplomacy has too often reproduced the very inequalities it aims to dismantle, operating within frameworks that privilege powerful nations and institutions while marginalizing voices from the Global South.

Lighting the Path: How the GlioLighT Consortium Is Exploring New Ways to Treat Brain Tumours

Lighting the Path: How the GlioLighT Consortium Is Exploring New Ways to Treat Brain Tumours

Across the world, scientists are still trying to answer one of medicine’s most difficult questions: how can we safely and effectively treat brain cancers such as glioma? Despite decades of effort, outcomes for people diagnosed with high-grade glioma remain bleak. Current treatments, including surgery, radiotherapy, and chemotherapy, can slow the disease, but rarely stop it. The GlioLighT consortium, a multidisciplinary European research team funded by the European Innovation Council, has come together to explore a novel approach based on direct light therapy. Being in a very early stage, the project doesn’t promise an immediate cure; instead, it sets out to answer a very fundamental question: can light itself trigger biological processes that might form the basis of a safe and targeted brain tumor therapy?

Prof. Vladimir Zharov | Detecting Malaria with Light and Sound Without Blood Draw Can Transform Global Health

Prof. Vladimir Zharov | Detecting Malaria with Light and Sound Without Blood Draw Can Transform Global Health

For centuries, malaria has been one of the deadliest diseases on the planet. Nearly half of the world remains at risk of malaria with more than half a million deaths each year, most of them in children. While some progress has been made in controlling malaria and developing a vaccine, this has stalled recently, with a growing number of deaths since 2019. At the heart of the challenge is the lack of non-invasive and rapid diagnostic technologies for malaria, which are urgently needed, especially in remote or low-resource areas with limited healthcare infrastructure. Happily, a new frontier in medical technology is offering hope, in the form of the Cytophone, a revolutionary device that can detect malaria through the skin without drawing a single drop of blood. This innovation, developed by a team led by Prof. Vladimir Zharov at the University of Arkansas for Medical Sciences and licensed to Cytoastra for further commercialization, represents a leap forward not just in malaria diagnostics, but in how we might monitor disease altogether.